Developer docs
API playgroundTry for free, no card

Search company profiles

BioIQ

Full company profile

uuid0002iqy

Namestring
BioIQ
Legal namestring
PrivaPath Diagnostics
Websiteurl
bioiq.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

BioIQ is a health improvement technology company founded in 2005 and headquartered in Atlanta that optimizes investments in corporate health and wellness programs. The company operates a vertically integrated at-home healthcare platform spanning owned high-complexity labs, in-house manufacturing and dispatch, telehealth staffed by physicians, nurses, and pharmacists, and a proprietary data and technology layer offering real-time visualizations and API integrations. Its core products include biometric screening, cancer (FIT) screening, gaps-in-care management, COVID-19 and infectious disease testing, genomics, and men's and women's health solutions.

BioIQ sells primarily through an enterprise direct-sales motion into five horizontal customer segments: healthcare providers, health plans, employers, public sector organizations, and life sciences companies. The platform is positioned to close gaps in care, support HEDIS measure compliance, expand access to clinical studies, and reduce barriers to care for underserved populations. Reported scale metrics include 5,000+ partner organizations, 2.5M gaps in care closed in 2021, 7M+ clinical interactions, 10M tests completed, and $201M in projected 5-year medical cost savings for a single health plan program. Following the 2025 consolidation under Fuze Health (legal entity PrivaPath Diagnostics), the corporate brand continues to operate as LetsGetChecked Powered by Fuze Health; strategic and partnership signals (Optum, Teladoc, Cigna, Salesforce, NCSD) and the prior BlipIQ acquisition support continued platform and ecosystem expansion.

Short descriptiontext

BioIQ is an Atlanta-based health technology company that operates a vertically integrated at-home healthcare platform serving 5,000+ organizations across providers, health plans, employers, public sector, and life sciences to close gaps in care and run biometric, cancer, genomic, and infectious-disease screening programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAtlanta, United States
HQ citystring
Atlanta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
at-home health testing, corporate wellness programs, biometric screening solutions, health plan care management, population health analytics
Industry3 codes
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAGAJAH
Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code3 codes
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Health Services8000
Product category
Healthcare Technology Platform
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

BioIQ is a health improvement technology company that delivers at-home healthcare and wellness solutions for businesses, health plans, employers, providers, and public sector organizations. Its platform enables partners to operationalize at-home biometric screenings, cancer screening, gaps in care closure, infectious disease testing, genomics, and men's and women's health programs. The offering combines proprietary technology, vertically integrated lab and logistics, telehealth services, and patient engagement tools to reduce barriers to care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 2.5M gaps in care closed in 2021
+4 more records
Product overview1 text field

LetsGetChecked is a vertically integrated at-home healthcare platform that owns the entire supply chain from manufacturing and dispatch to care and treatment. The platform offers a unified ecosystem combining multiple testing solutions (Biometrics Screening, Cancer Screening, Genomics, Infectious Disease Testing, Men's Health, Women's Health) with core platform capabilities (Lab & Logistics, Telehealth, Patient Engagement, Data & Technology). The platform serves health plans, employers, providers, public sector, and life sciences organizations, enabling them to utilize at-home healthcare programs to reduce barriers to access.

Product and service8 records
1Biometrics Screening
CategoryAt-home Health Screening
Description

Comprehensive biometric health screenings that enable early detection of disease risk for health plan, employer, and provider populations.

2Cancer Screening
CategoryAt-home Health Screening
Description

Non-invasive FIT testing solution that helps members identify blood in the stool early for colorectal cancer screening.

3Gaps in Care
CategoryCare Management
Description

Solution that helps members manage conditions and improve compliance with health screenings to meet HEDIS measures for health plans.

4COVID-19 Testing
CategoryInfectious Disease Testing
Description

Comprehensive COVID-19 screening program to ensure a safe environment for workplaces and organizations.

5Genomics
CategoryAt-home Health Screening
Description

Genomic sequencing solutions designed to inform clinical decisions in an approachable way for patient populations.

6Infectious Disease Testing
CategoryInfectious Disease Testing
Description

Wide range of testing and treatment options to reduce the spread of infectious disease, with multi-site test kits available for populations.

7Men's Health
CategoryAt-home Health Screening
Description

Screening solutions addressing common hormonal imbalances and health risks that affect men, offered through at-home programs.

8Women's Health
CategoryAt-home Health Screening
Description

Hormone insights for family planning and overall well-being to empower women's health, delivered through at-home test kits.

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Logo partner displayed on LetsGetChecked for Business website. Optum is a major healthcare technology and services company.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Logo partner displayed on LetsGetChecked for Business website. Teladoc is a leading virtual healthcare services provider.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Logo partner displayed on LetsGetChecked for Business website. NCSD is a public health organization focused on STD prevention.

Strategic tierCoreTypeTechnology or Integration
Description

Logo partner displayed on LetsGetChecked for Business website. Salesforce is a major CRM platform with healthcare cloud solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Logo partner displayed on LetsGetChecked for Business website. Cigna is a major global health insurance company.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeDirect peer
Description

Vertically integrated telehealth and at-home diagnostics provider covering men's health, women's health, and chronic conditions through a platform combining labs, telehealth, and pharmacy.

TypeDirect peer
Description

Direct at-home diagnostic testing competitor offering consumer and enterprise health testing with a similar multi-channel distribution model targeting health plans and employers.

TypeBroad incumbent
Description

Diversified health services and technology giant (part of UnitedHealth Group) offering population health, analytics, and care delivery — already a BioIQ partner and competitor in enterprise health programs.

4Cue Health
TypeDirect peer
Description

At-home and enterprise diagnostic testing company (notably COVID-19) with platform approach to molecular testing, competing directly for enterprise and public sector contracts.

TypeBroad incumbent
Description

Largest virtual care incumbent whose enterprise platform includes chronic care, mental health, and integrated lab services, overlapping with BioIQ's telehealth and gaps-in-care capabilities for payers and employers.

TypeDirect peer
Description

Directly comparable at-home testing and virtual care platform; the source data describes BioIQ's offerings as LetsGetChecked's vertically integrated platform, indicating the two are operationally intertwined.

TypeEmerging player
Description

Population-scale genetic testing and virtual care company with enterprise and public health contracts; intersects with BioIQ's genomics and gaps-in-care offerings for health plans and life sciences.

TypeBroad incumbent
Description

Major reference laboratory offering direct-to-consumer and enterprise testing services; a broad incumbent competing in the same lab diagnostics and employer wellness space.

TypeBroad incumbent
Description

Global clinical laboratory network with employer wellness, biometric screening, and at-home testing offerings — directly comparable to BioIQ's health plan and employer solutions.

TypeDirect peer
Description

Direct-to-consumer virtual care and at-home testing platform with overlapping men's and women's health, telehealth, and lab diagnostics offerings aimed at similar end users.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioIQ

Healthcare Technology Platformbioiq.com

BioIQ is an Atlanta-based health technology company that operates a vertically integrated at-home healthcare platform serving 5,000+ organizations across providers, health plans, employers, public sector, and life sciences to close gaps in care and run biometric, cancer, genomic, and infectious-disease screening programs.

What BioIQ does

BioIQ is a health improvement technology company founded in 2005 and headquartered in Atlanta that optimizes investments in corporate health and wellness programs. The company operates a vertically integrated at-home healthcare platform spanning owned high-complexity labs, in-house manufacturing and dispatch, telehealth staffed by physicians, nurses, and pharmacists, and a proprietary data and technology layer offering real-time visualizations and API integrations. Its core products include biometric screening, cancer (FIT) screening, gaps-in-care management, COVID-19 and infectious disease testing, genomics, and men's and women's health solutions.

BioIQ sells primarily through an enterprise direct-sales motion into five horizontal customer segments: healthcare providers, health plans, employers, public sector organizations, and life sciences companies. The platform is positioned to close gaps in care, support HEDIS measure compliance, expand access to clinical studies, and reduce barriers to care for underserved populations. Reported scale metrics include 5,000+ partner organizations, 2.5M gaps in care closed in 2021, 7M+ clinical interactions, 10M tests completed, and $201M in projected 5-year medical cost savings for a single health plan program. Following the 2025 consolidation under Fuze Health (legal entity PrivaPath Diagnostics), the corporate brand continues to operate as LetsGetChecked Powered by Fuze Health; strategic and partnership signals (Optum, Teladoc, Cigna, Salesforce, NCSD) and the prior BlipIQ acquisition support continued platform and ecosystem expansion.

BioIQ firmographics

Firmographics
Name
BioIQ
Legal name
PrivaPath Diagnostics
Website
https://bioiq.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
BioIQ is an Atlanta-based health technology company that operates a vertically integrated at-home healthcare platform serving 5,000+ organizations across providers, health plans, employers, public sector, and life sciences to close gaps in care and run biometric, cancer, genomic, and infectious-disease screening programs.
Ownership category
akta.pro rank

BioIQ industry classification

Industry
Product category
Healthcare Technology Platform
NAICS
Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Computer Systems Design and Related Services (54151)
SIC
Services-Medical Laboratories (8071), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAGAJAH
Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • At-home health testing
  • Corporate wellness programs
  • Biometric screening solutions
  • Health plan care management
  • Population health analytics

Where BioIQ is headquartered

Location

Headquarters

HQ city
Atlanta
HQ country
United States
HQ region
North America

Markets served

BioIQ business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

BioIQ product offering

Product offering

Core offering

BioIQ is a health improvement technology company that delivers at-home healthcare and wellness solutions for businesses, health plans, employers, providers, and public sector organizations. Its platform enables partners to operationalize at-home biometric screenings, cancer screening, gaps in care closure, infectious disease testing, genomics, and men's and women's health programs. The offering combines proprietary technology, vertically integrated lab and logistics, telehealth services, and patient engagement tools to reduce barriers to care.

Product overview

LetsGetChecked is a vertically integrated at-home healthcare platform that owns the entire supply chain from manufacturing and dispatch to care and treatment. The platform offers a unified ecosystem combining multiple testing solutions (Biometrics Screening, Cancer Screening, Genomics, Infectious Disease Testing, Men's Health, Women's Health) with core platform capabilities (Lab & Logistics, Telehealth, Patient Engagement, Data & Technology). The platform serves health plans, employers, providers, public sector, and life sciences organizations, enabling them to utilize at-home healthcare programs to reduce barriers to access.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biometrics Screening Comprehensive biometric health screenings that enable early detection of disease risk for health plan, employer, and provider populations.
  • Cancer Screening Non-invasive FIT testing solution that helps members identify blood in the stool early for colorectal cancer screening.
  • Gaps in Care Solution that helps members manage conditions and improve compliance with health screenings to meet HEDIS measures for health plans.
  • COVID-19 Testing Comprehensive COVID-19 screening program to ensure a safe environment for workplaces and organizations.
  • Genomics Genomic sequencing solutions designed to inform clinical decisions in an approachable way for patient populations.
  • Infectious Disease Testing Wide range of testing and treatment options to reduce the spread of infectious disease, with multi-site test kits available for populations.
  • Men's Health Screening solutions addressing common hormonal imbalances and health risks that affect men, offered through at-home programs.
  • Women's Health Hormone insights for family planning and overall well-being to empower women's health, delivered through at-home test kits.

Quantifiable outcome

  • 2.5M gaps in care closed in 2021
  • +4 more outcomes

Companies that use BioIQ

Customer profile

Segments5 records

Ideal customer profiles5 records

BioIQ technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioIQ partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • OptumcoreStrategic or Co-development PartnerLogo partner displayed on LetsGetChecked for Business website. Optum is a major healthcare technology and services company.
  • TeladoccoreStrategic or Co-development PartnerLogo partner displayed on LetsGetChecked for Business website. Teladoc is a leading virtual healthcare services provider.
  • NCSD (National Coalition of STD Directors)coreStrategic or Co-development PartnerLogo partner displayed on LetsGetChecked for Business website. NCSD is a public health organization focused on STD prevention.
  • SalesforcecoreTechnology or IntegrationLogo partner displayed on LetsGetChecked for Business website. Salesforce is a major CRM platform with healthcare cloud solutions.
  • CignacoreStrategic or Co-development PartnerLogo partner displayed on LetsGetChecked for Business website. Cigna is a major global health insurance company.

Recent moves6 records

Expansion highlights5 records

BioIQ competitors and assessment

Company assessment

Direct peers

  • Ro: Vertically integrated telehealth and at-home diagnostics provider covering men's health, women's health, and chronic conditions through a platform combining labs, telehealth, and pharmacy.
  • Everlywell: Direct at-home diagnostic testing competitor offering consumer and enterprise health testing with a similar multi-channel distribution model targeting health plans and employers.
  • Cue Health: At-home and enterprise diagnostic testing company (notably COVID-19) with platform approach to molecular testing, competing directly for enterprise and public sector contracts.
  • LetsGetChecked: Directly comparable at-home testing and virtual care platform; the source data describes BioIQ's offerings as LetsGetChecked's vertically integrated platform, indicating the two are operationally intertwined.
  • Hims & Hers Health: Direct-to-consumer virtual care and at-home testing platform with overlapping men's and women's health, telehealth, and lab diagnostics offerings aimed at similar end users.

Broad incumbents

  • Optum: Diversified health services and technology giant (part of UnitedHealth Group) offering population health, analytics, and care delivery — already a BioIQ partner and competitor in enterprise health programs.
  • Teladoc Health: Largest virtual care incumbent whose enterprise platform includes chronic care, mental health, and integrated lab services, overlapping with BioIQ's telehealth and gaps-in-care capabilities for payers and employers.
  • Quest Diagnostics: Major reference laboratory offering direct-to-consumer and enterprise testing services; a broad incumbent competing in the same lab diagnostics and employer wellness space.
  • Labcorp: Global clinical laboratory network with employer wellness, biometric screening, and at-home testing offerings — directly comparable to BioIQ's health plan and employer solutions.

Emerging players

  • Color Health: Population-scale genetic testing and virtual care company with enterprise and public health contracts; intersects with BioIQ's genomics and gaps-in-care offerings for health plans and life sciences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BioIQ social profiles

Digital presence

BioIQ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioIQ leadership team

Management profile

Number of profiles

Profiles4 records

BioIQ funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioIQ M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioIQ

What does BioIQ do?

BioIQ is a health improvement technology company that delivers at-home healthcare and wellness solutions for businesses, health plans, employers, providers, and public sector organizations. Its platform enables partners to operationalize at-home biometric screenings, cancer screening, gaps in care closure, infectious disease testing, genomics, and men's and women's health programs. The offering combines proprietary technology, vertically integrated lab and logistics, telehealth services, and patient engagement tools to reduce barriers to care.

Is BioIQ a public or private company?

BioIQ is a private company. It is classified as venture growth investor backed and is currently operating.

When was BioIQ founded?

BioIQ was founded in 2005. It employs 11 to 50 people.

Where is BioIQ based?

BioIQ is headquartered in Atlanta, United States, in the North America region.

Who are BioIQ's main competitors?

Direct peers on record are Ro, Everlywell, Cue Health, LetsGetChecked and Hims & Hers Health. Broad incumbents are Optum, Teladoc Health, Quest Diagnostics and Labcorp. Color Health is listed as an emerging player.

Does BioIQ have an API?

No public API is recorded for BioIQ.

What industry is BioIQ in?

BioIQ's product category is Healthcare Technology Platform. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DarkdailyDirect-to-Consumer Health Testing Company LetsGetChecked Acquires Veritas Genetics, Veritas Intercontinental, and BioIQLetsGetChecked has acquired Veritas Genetics, including its Veritas Intercontinental division, as well as diagnostic company BioIQ to expand its direct-to-consumer health testing capabilities. The acquisition brings whole genome sequencing technology to LetsGetChecked, allowing it to launch comprehensive personalized healthcare solutions integrating genetic insights with virtual care infrastructure. These moves are part of a strategic pivot by LetsGetChecked to scale its at-home diagnostics and biometric screening offerings.Business Wire BlogLetsGetChecked Completes Acquisition of BioIQLetsGetChecked finalized its acquisition of BioIQ, an analytics-driven population health and diagnostics company. The deal expands LetsGetChecked's at-home healthcare services for health plans, employers, and consumers, with BioIQ operating as a wholly-owned subsidiary. The acquisition follows LetsGetChecked's earlier purchase of Veritas Genetics and Veritas Intercontinental.PR NewswireBioIQ Announces the Addition of 26 New Health Plan Customers in 2021BioIQ announced the addition of 26 new health plan customers in 2021, expanding its client base to cover more than 7 out of 10 fully insured American lives. These clients utilize BioIQ's digital platform for at-home health testing, vaccination strategies, and engagement initiatives to address deferred medical care caused by the pandemic. The company reported continued momentum as health plans sought proven solutions to meet strategic healthcare goals and improve clinical adherence.PR NewswireBioIQ and DermTech Enter into an Agreement to Add Non-invasive DermTech Melanoma Test to BioIQ's Health Testing Solution LineupBioIQ and DermTech announced an agreement to add the DermTech Melanoma Test to BioIQ's health testing platform for employers and health plans, initially launching in Florida with planned expansion to other states. The non-invasive test uses DermTech's Smart Sticker technology for at-home skin sample collection via telemedicine consultations, addressing delays in preventive cancer screenings caused by the pandemic. Both companies aim to improve early melanoma detection while reducing costs and inconvenience compared to traditional biopsy procedures.PR NewswireBioIQ Ranked One of the Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™BioIQ was ranked on the 2021 Deloitte Technology Fast 500 list, marking its fifth inclusion in eight years due to record revenue growth driven by demand for at-home health testing. The company expanded its client base with Fortune 500 firms and government agencies while capitalizing on the shift toward remote diagnostic solutions during the pandemic. Additionally, BioIQ announced an agreement to be acquired by LetsGetChecked to further integrate its testing platform.Business Wire BlogLetsGetChecked to Acquire BioIQLetsGetChecked announced its intention to acquire BioIQ, an analytics-driven population health and testing platform. The deal is expected to close in the fourth fiscal quarter of this year, subject to regulatory approvals. BioIQ will operate as a wholly-owned subsidiary.BioSpaceSeqster Combines BioIntelliSense Continuous Health Monitoring Data with EHR and Genomic Data to Advance Remote CareSeqster announced a collaboration with BioIntelliSense to combine continuous health monitoring data from BioSticker and BioButton devices with EHR and genomic data for remote patient monitoring. The partnership aims to enable personalized care and risk stratification through real-time data integration.PR NewswireAs Care Shifts to the Home, BioIQ Earns Timely Certification from Validation Institute for Cost and Outcome Improvements Through Health Testing ServicesBioIQ, an analytics-driven population health and testing platform company, has received Level 1 and Level 2 Validation Certificates from Validation Institute for its health testing services, verifying cost savings and outcome improvements in colorectal cancer screening. The validation confirms that BioIQ achieved a 30% health screening gap closure rate for two-year engagement programs from 2018 to 2019, demonstrating measurable impact on healthcare costs and outcomes. The certification positions BioIQ to differentiate itself among value-based, cost-conscious solution providers as demand for convenient at-home and retail testing grows amid the COVID-19 pandemic.PR NewswireBioIQ Approaches Milestone of One Million COVID-19 Tests and Record Health Testing in the Home as Delta Variant Cases ClimbBioIQ is preparing to conduct its one millionth COVID-19 test, marking the busiest year in the company's 15-year history as demand for at-home health testing solutions surges due to the Delta variant. The company has expanded its client base to include Fortune 500 companies and government agencies while adding specialized laboratory partners to offer new saliva-based and multi-panel testing solutions.BioSpaceBioIQ Announces Webinar with Cambia Health Solutions Senior Vice President of Health Care Services Dr. Marion Couch on How COVID-19 Drove Innovation in HealthcareBioIQ announced an on-demand webinar featuring Dr. Marion Couch, Cambia Health Solutions SVP of Health Care Services, and Justin Bellante, founder and COO, discussing how COVID-19 drove healthcare innovation. They covered telehealth, vaccine distribution, and care management models, with both leaders citing pandemic lessons as a catalyst for transformation.